Raia Drogasil S.A.
RADLY
$3.56
-$0.26-6.81%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.80% | 16.24% | 6.18% | -1.97% | -5.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.80% | 16.24% | 6.18% | -1.97% | -5.34% |
| Cost of Revenue | 21.31% | 15.48% | 5.71% | -2.39% | -5.85% |
| Gross Profit | 26.24% | 18.02% | 7.30% | -0.98% | -4.13% |
| SG&A Expenses | 23.45% | 15.91% | 7.15% | -0.12% | -3.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 972.96% | 1,314.17% | -375.57% | 67.87% | 81.04% |
| Total Operating Expenses | 22.53% | 16.21% | 5.98% | -1.69% | -5.07% |
| Operating Income | 27.08% | 16.80% | 9.24% | -6.20% | -9.33% |
| Income Before Tax | 27.02% | 4.66% | -5.01% | -11.78% | -13.70% |
| Income Tax Expenses | 78.82% | -16.22% | -24.78% | -70.00% | -55.29% |
| Earnings from Continuing Operations | 21.92% | 7.40% | -1.38% | 3.09% | -5.00% |
| Earnings from Discontinued Operations | -73.15% | 223.69% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.13% | 74.55% | 76.52% | 44.71% | 57.81% |
| Net Income | 17.60% | 11.89% | 5.82% | 11.04% | 3.37% |
| EBIT | 27.08% | 16.80% | 9.24% | -6.20% | -9.33% |
| EBITDA | 26.50% | 18.43% | 10.77% | -4.78% | -7.76% |
| EPS Basic | 20.94% | 31.20% | 23.03% | 28.36% | 20.85% |
| Normalized Basic EPS | 25.03% | 18.37% | 10.82% | -3.30% | -0.72% |
| EPS Diluted | 20.00% | 30.47% | 22.87% | 28.31% | 20.72% |
| Normalized Diluted EPS | 24.21% | 17.21% | 10.38% | -3.65% | -1.08% |
| Average Basic Shares Outstanding | -2.98% | -17.71% | -17.34% | -16.36% | -16.76% |
| Average Diluted Shares Outstanding | -2.30% | -16.74% | -16.96% | -16.04% | -16.38% |
| Dividend Per Share | -3.37% | 73.10% | 211.45% | -38.79% | 13.10% |
| Payout Ratio | 0.00% | 0.23% | 0.30% | -0.09% | -0.02% |